Treatment with telitacicept for 39 weeks resulted in a rapid, clinically meaningful, and statistically significant reduction ...
It also took the spot as the 12th leading cause of disability-adjusted life-years (DALYs), with an age-standardized DALY rate ...
Oncologist Dr Satheesh warns of rising lung cancer cases among non-smokers in India, attributing it to pollution and indoor smoke.
12h
Boehringer awarded FDA Commissioner's National Priority Voucher for HERNEXEOS(R) in HER2 lung cancer
Boehringer recently reported positive results from the Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced NSCLC at ESMO 2025. The company is pursuing regulatory ...
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, today announced results from new post hoc analyses of the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback